Spontaneous Intracerebral Hemorrhage in a Patient with Asymptomatic 2019 Novel Coronavirus Disease

참고문헌 (11)

1. Mao L, "Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China", JAMA Neurol, pp.e201127~ (2020)
2. Avula A, "COVID-19 presenting as stroke", Brain Behav Immun (2020)[DOI]
3. Sharifi-Razavi A, "COVID-19 and intracerebral haemorrhage : causative or coincidental?", New Microbes New Infect, 35, pp.100669~ (2020)
4. Hoffmann M, "SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor", Cell, 181, pp.271~280.e8 (2020)
5. Hamming I, "Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis", J Pathol, 203, pp.631~637 (2004)
6. Doobay MF, "Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system", Am J Physiol Regul Integr Comp Physiol, 292, pp.R373~R381 (2007)
7. Wang HY, "Potential neurological symptoms of COVID-19", Ther Adv Neurol Disord, 13, pp.1756286420917830~ (2020)
8. Khosravani H, "Protected code stroke: hyperacute stroke management during the coronavirus disease 2019 (COVID-19) pandemic", Stroke, 51, pp.1891~1895 (2020)
9. Hemphill JC 3rd, "Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association", American Stroke Association, 2015, pp.46, 2032~2060
10. Savarino A, "Effects of chloroquine on viral infections: an old drug against today’s diseases?", Lancet Infect Dis, 3, pp.722~727 (2003)
11. Gautret P, "Hydroxychloroquine and azithromycin as a treatment of COVID-19 : results of an open-label non-randomized clinical trial", Int J Antimicrob Agents, pp.105949~ (2020)

관련 논문AI추천